The Food and Drug Administration has approved Ozempic ® (semaglutide) to reduce the risk of sustained estimated glomerular ...
Veteran Leader Brings Extensive Expertise in Rare Disease, including Renal Disease, and a Track Record of Regulatory Success with Orphan Diseases and Breakthrough Therapy DesignationsCAMBRIDGE, Mass., ...
Children with AAV and kidney disease face increased risks for long-term renal damage at 1 year, despite the majority achieving inactive renal disease by this time.
Statins, which are prescription drugs that can reduce cholesterol levels and lower the risk for heart disease, don’t affect kidney function, new research shows.
Patients with CKD who use antiresorptive drugs for tumor-related disorders or oral corticosteroids may be at increased risk for osteonecrosis of the jaw.
In line with trial results, real-world data suggest GLP-1 receptor agonists have certain benefits in patients with moderate to severe chronic kidney disease (CKD).
The present case and others in the literature indicate that the presence of hydronephrosis, even if associated with no apparent glomerular ... kidney. In patients with cystic renal diseases ...
The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...
Scientist develop new equation for detecting hyperfiltration that incorporates age but not body surface area. Read more!
Dr. Janine Zee-Cheng, a board-certified pediatrician in Indiana, told HuffPost that sometimes a child will come in with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback